Evaluation of polyneuropathy markers in type 1 diabetic kidney transplant patients and effects of islet transplantation: Neurophysiological and skin biopsy longitudinal analysis

Diabetes Care

Volumn 30, Issue 12, 2007, Pages 3063-3069

  Del Carro, Ubaldo ^a   Fiorina, Paolo ^a,b,d   Amadio, Stefano ^a   Franceschini, Luisa De Toni ^a   Petrelli, Alessandra ^a   Menini, Stefano ^c   Boneschi, Filippo Martinelli ^a   Ferrari, Stefania ^a   Pugliese, Giuseppe ^c   Maffi, Paola ^a   Comi, Giancarlo ^a,d   Secchi, Antonio ^a,d  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; IMMUNOSUPPRESSIVE AGENT; INSULIN; ORAL ANTIDIABETIC AGENT;

ACTION POTENTIAL; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GRAFT REJECTION; HUMAN; HUMAN TISSUE; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FAILURE; KIDNEY GRAFT; MALE; PANCREAS ISLET TRANSPLANTATION; PERINEURIUM; POLYNEUROPATHY; SKIN BIOPSY;

ADULT; BIOLOGICAL MARKERS; BIOPSY; C-PEPTIDE; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; DIABETIC NEUROPATHIES; ELECTROPHYSIOLOGY; HUMANS; ISLETS OF LANGERHANS TRANSPLANTATION; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LONGITUDINAL STUDIES; MIDDLE AGED; PERIPHERAL NERVES; SKIN;

EID: 37149048164     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc07-0206     Document Type: Article

References (27)

1. Dyck PJ, Kratz KM, Karnes JL, Litchy WJ, Klein R, Pach JM, Wilson DM, O'Brien PC, Melton LJ III: The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology 43:817-824, 1993
2. Boulton AJM, Malik RA, Arezzo JC, Sosenko JM: Diabetic somatic neuropathies. Diabetes Care 27:1458-1486, 2004
3. Carrington AL, Shaw JE, Van Schie CHM; Abbott CA, Vileikite L, Boulton AJM: Can motor nerve conduction velocity predict foot problems in diabetic subjects over a 6-year outcome period? Diabetes Care 25:2010-2015, 2002
4. Kennedy WR, Navarro X, Goetz FC, Sutherland DE, Najaran JS: Effects of pancreatic transplantation on diabetic neuropathy. NEngl J Med 322:1031-1037,1990
5. The Diabetes Control and Complication Trial Research Group: The effect of intensive treatment of diabetes on development and progression of long term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
6. Bertuzzi F, Secchi A, Di Carlo V: Islet transplantation in type 1 diabetic patients. Transplant Proc 36:603- 604, 2004
7. Ryan EA, Lakey JRT, Paty BW, Imes S, Korbutt GS, Kneteman NM, Bigam D, Rajotte RV, Shapiro AMJ: Successful islet transplantation: continued insulin reserve provides long-term glycemic control. Diabetes 51:2148-2157, 2002
8. Shapiro AMJ, Lakey JRT, Ryan EA, Korbutt GS, Toth E, Warnock GL, Kneteman NM, Rajotte RV: Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 343:230-238, 2000
9. Gruessner RW, Sutherland DE, Troppmann C, Benedetti E, Hakim N, Dunn DL, Gruessner AC: The surgical risk of pancreas transplantation in the cyclosporine era: an overview. J Am Coll Surg 185:128-144, 1997
10. Senior PA, Paty BW, Cockfield SM, Ryan EA, Shapiro AMJ: Proteinuria developing after clinical islet transplantation resolves with sirolimus withdrawal and increased tacrolimus dosing. Am J Transplant 5:2318-2323, 2005
11. Fiorina P, Folli F, Zerbini G, Maffi P, Gremizzi C, Di Carlo V, Socci C, Bertuzzi F, Kashgarian M, Secchi A: Islet transplantation is associated with improvement of renal function among uremic patients with type I diabetes mellitus and kidney transplants. J Am Soc Nephrol 14:2150-2158, 2003
12. Fiorina P, Venturini M, Folli F, Losio C, Maffi P, Placidi C, La Rosa S, Orsenigo E, Socci C, Capella C, Del Maschio A, Secchi A: Natural history of kidney graft survival, hypertrophy, and vascular function in end-stage renal disease type 1 diabetic kidney-transplanted patients. Diabetes Care 28:1303-1310, 2005
13. Fiorina P, Folli F, Bertuzzi F, Maffi P, Finzi G, Venturini M, Socci C, Davalli A, Orsenigo E, Monti L, Falqui L, Uccella S, La Rosa S, Usellini U, Properzi G, Di Carlo V, Del Maschio A, Capella C, Secchi A: Long-term beneficial effect of islet transplantation on diabetic macro-/microangiopathy in type 1 diabetic kidney-transplanted patients. Diabetes Care 26:1129-1136, 2003
14. Fiorina P, Gremizzi C, Maffi P, Caldara R, Tavano D, Monti L, Socci C, Folli F, Fazio F, Astorri E, Del Maschio A, Secchi A: Islet transplantation is associated with an improvement of cardiovascular function in type 1 diabetic kidney transplant patients. Diabetes Care 28:1358-1365, 2005
15. Várkonyi TT, Farkas G, Fülöp Z, Vörös P, Lengyel CS, Kempler P, Lonovics J: Beneficial effect of fetal islet grafting on development of late diabetic complications. Transplant Proc 30:330-331, 1998
16. Lee TC, Barshes NR, O'Mahony CA, Nguyen L, Brunicardi FC, Ricordi C, Alejandro R, Schock AP, Mote A, Goss JA: The effect of pancreatic islet transplantation on progression of diabetic retinopathy and neuropathy. Transplant Proc 37:2263-2265, 2005
17. King RH: The role of glycation in the pathogenesis of diabetic polyneuropathy. Mol Pathol 54:400-408, 2001
18. Report and recommendation of the San Antonio conference on diabetic neuropathy: consensus statement. Diabetes 37:1000-1004, 1988
19. Fiorina P, La Rocca E, Venturini M, Minicucci F, Fermo I. Paroni R, D'Angelo A, Sblendido M, Di Carlo V, Cristallo M, Del Maschio A, Pozza G, Secchi A: Effects of kidney-pancreas transplantation on atherosclerotic risk factors and endothelial function in patients with uremia and type 1 diabetes. Diabetes 50:496-501, 2001
20. Martinenghi S, Comi G, Galardi G, Di Carlo V, Pozza G, Secchi A: Amelioration of nerve conduction velocity following simultaneous kidney/pancreas transplantation is due to the glycaemic control provided by the pancreas. Diabetologia 40:1110-1112, 1997
21. Krarup C: An update on electrophysiological studies in neuropathy. Curr Opin Neurol 16:603-612, 2003
22. Bolton CF: Peripheral neuropathies associated with chronic renal failure. Can J Neurol Sci 7:89-96, 1980
23. Ekberg K, Brismar T, Johansson BL, Jonsson B, Lindström P, Wahren J: Amelioration of sensory nerve dysfunction by C-peptide in patients with type 1 diabetes. Diabetes 52:536-541, 2003
24. Di Mario U, Pugliese G: 15th Golgi Lecture: from hyperglycaemia to the dysregulation of vascular remodelling in diabetes. Diabetologia 44:674-692, 2001
25. Sugimoto K, Nishizawa Y, Horiuchi S, Yagihashi S: Localization in human diabetic peripheral nerve of Nε-carboxymethyllysine-protein adducts, an advanced glycation endproduct. Diabetologia 40:1380-1387, 1997
26. Tanji N, Markowitz GS, Fu C, Kislinger T, Taguchi A, Pischetsrieder M, Stern D, Schmidt AM, D'Agati VD: Expression of advanced glycation end products and their cellular receptor RAGE in diabetic nephropathy and nondiabetic renal disease. J Am Soc Nephrol 11:1656 -66, 2000
27. Tankisi H, Pugdahl K, Fuglsang-Frederiksen A, Johnsen B, de Carvalho M, Fawcett PRW, Labarre-Vila A, Liguori R, Nix WA, Schofield IS: Pathophysiology inferred from electrodiagnostic nerve tests and classification of polyneuropathies. Suggested guidelines. Clin Neurophysiol 116:1571-1580, 2005